122 related articles for article (PubMed ID: 20089166)
21. Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization.
Han CP; Lee MY; Tzeng SL; Yao CC; Wang PH; Cheng YW; Chen SL; Wu TS; Tyan YS; Kok LF
J Exp Clin Cancer Res; 2008 Aug; 27(1):25. PubMed ID: 18673574
[TBL] [Abstract][Full Text] [Related]
22. Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking.
Hübner RH; Schwartz JD; De Bishnu P; Ferris B; Omberg L; Mezey JG; Hackett NR; Crystal RG
Mol Med; 2009; 15(7-8):203-19. PubMed ID: 19593404
[TBL] [Abstract][Full Text] [Related]
23. Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD.
Tien CP; Chen CH; Lin WY; Liu CS; Liu KJ; Hsiao M; Chang YC; Hung SC
Aging (Albany NY); 2019 Jul; 11(13):4654-4671. PubMed ID: 31299012
[TBL] [Abstract][Full Text] [Related]
24. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
Yang B; O'Herrin SM; Wu J; Reagan-Shaw S; Ma Y; Bhat KM; Gravekamp C; Setaluri V; Peters N; Hoffmann FM; Peng H; Ivanov AV; Simpson AJ; Longley BJ
Cancer Res; 2007 Oct; 67(20):9954-62. PubMed ID: 17942928
[TBL] [Abstract][Full Text] [Related]
25. [p53 gene expression and activation of p53-dependent transcription in melanoma cell lines].
Mol Biol (Mosk); 2005; 39(3):445-56. PubMed ID: 15981574
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
27. Expression of Skp2 and p27KIP1 in naevi and malignant melanoma of the skin and its relation to clinical outcome.
Woenckhaus C; Maile S; Uffmann S; Bansemir M; Dittberner T; Poetsch M; Giebel J
Histol Histopathol; 2005 Apr; 20(2):501-8. PubMed ID: 15736055
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
29. Critical role for non‑GAP function of Gαs in RGS1‑mediated promotion of melanoma progression through AKT and ERK phosphorylation.
Sun MY; Wang Y; Zhu J; Lv C; Wu K; Wang XW; Xue CY
Oncol Rep; 2018 Jun; 39(6):2673-2680. PubMed ID: 29620236
[TBL] [Abstract][Full Text] [Related]
30. WT 1 expression in nevi and melanomas: a marker of melanocytic invasion into the dermis.
Garrido-Ruiz MC; Rodriguez-Pinilla SM; Pérez-Gómez B; Rodriguez-Peralto JL
J Cutan Pathol; 2010 May; 37(5):542-8. PubMed ID: 19638168
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of PIR gene expression induced by human papillomavirus E6 and E7 in epithelial oral and cervical cells.
Carrillo D; Muñoz JP; Huerta H; Leal G; Corvalán A; León O; Calaf GM; Urzúa U; Boccardo E; Tapia JC; Aguayo F
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118270
[TBL] [Abstract][Full Text] [Related]
32. Functional proteomic analysis of melanoma progression.
Bernard K; Litman E; Fitzpatrick JL; Shellman YG; Argast G; Polvinen K; Everett AD; Fukasawa K; Norris DA; Ahn NG; Resing KA
Cancer Res; 2003 Oct; 63(20):6716-25. PubMed ID: 14583466
[TBL] [Abstract][Full Text] [Related]
33. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Becker JC; Ruiter DJ; van Muijen GN
J Invest Dermatol; 2000 Oct; 115(4):625-32. PubMed ID: 10998134
[TBL] [Abstract][Full Text] [Related]
35. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
[TBL] [Abstract][Full Text] [Related]
36. HER3 is a determinant for poor prognosis in melanoma.
Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
[TBL] [Abstract][Full Text] [Related]
37. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
38. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
40. Nuclear ING2 expression is reduced in human cutaneous melanomas.
Lu F; Dai DL; Martinka M; Ho V; Li G
Br J Cancer; 2006 Jul; 95(1):80-6. PubMed ID: 16755297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
